Riskpilot← Back to searchSign inGet full accessNORMEDICAL GROUP AS
ASActiveOrg 983640117Drammensveien 50D, 0271 OsloManufacture of medical and dental instruments and supplies · NACE 3250Est. 20010 employeeswww.normedical.com
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 0
-100% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | -100% |
| Total assets | NOK 1 | -100% |
| Equity | NOK 1 | +0% |
| Employees | 0 | — |
Legal name
NORMEDICAL GROUP AS
Org number
983640117
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
6. september 2001
Share capital
NOK 75 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering og drift av andre selskap. Handel og agentur, import og eksport, salg av varer og rådgivningstjenester, samt alt som står i forbindelse med dette, herunder deltagelse i andre selskaper med samme eller lignende formål. Investere i verdipapirer inklusiv aksjer og andre sertifikater og obligasjoner, så vel som andre selskaper eller forretningsvirksomheter av enhver art, direkte eller indirekte. Gjøre alt det nødvendige eller hensiktsmessige for oppfyllelse av de ovennevnte formål eller hva som er forbundet med dem i videste forstand.
Address
Drammensveien 50D, 0271 Oslo
Website
www.normedical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 597 | 729 | 658 | 0 | 0 | 0 | 55 | 10 | 22 | 32 | 0 | 36 | 0 | 28 | 0 | 0 | 0 |
| Staff expenses | −86 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 206 | −10 | −66 | −106 | −30 | −23 | −26 | −67 | −50 | −84 | −301 | −35 | −4 | 20 | −225 | 93 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 206 | −10 | −66 | −106 | −30 | −23 | −26 | −67 | −50 | −84 | −301 | −35 | −4 | 20 | −225 | 93 | 0 |
| Net financials | 24 | −101 | 196 | 100 | 0 | −2 | −98 | −309 | −52 | −15 | 4 | −2 | 0 | −0 | −4 300 | 0 | 0 |
| Profit before tax | 230 | −111 | 131 | −6 | −30 | −24 | −124 | −376 | −102 | −99 | −297 | −37 | −4 | 20 | −4 525 | 93 | 0 |
| Tax | 65 | −31 | 36 | −0 | −0 | −0 | −35 | −91 | −19 | −17 | −58 | −8 | −1 | 230 | −0 | −0 | −0 |
| Net profit | 165 | −80 | 94 | −6 | −30 | −24 | −89 | −285 | −82 | −82 | −239 | −29 | −3 | −209 | −4 525 | 93 | 0 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 697 | 992 | 1 009 | 96 | 1 131 | 810 | 1 743 | 2 027 | 2 667 | 2 812 | 6 726 | 4 876 | 4 881 | 4 525 | 0 | 98 | 0 |
| Equity | 868 | 788 | 600 | 95 | 65 | 391 | 552 | 417 | 2 590 | 2 695 | 2 456 | 4 645 | 4 641 | 4 432 | −93 | 0 | 0 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 829 | 203 | 408 | 2 | 1 066 | 420 | 1 191 | 1 610 | 77 | 117 | 4 270 | 231 | 239 | 93 | 93 | 98 | 0 |
| Total debt | 829 | 203 | 408 | 2 | 1 066 | 420 | 1 191 | 1 610 | 77 | 117 | 4 270 | 231 | 239 | 93 | 93 | 98 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20082024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20082024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20082024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20082024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20082024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Entreprenør Svein Oves As | Company | 46.9% | 46.9% | 2022 |
Scientia Invest As | Company | 24.6% | 24.6% | 2022 |
Coas As | Company | 24.6% | 24.6% | 2022 |
Maginel As | Company | 1.7% | 1.7% | 2022 |
Cap Nord Holding As | Company | 1.3% | 1.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scientia Invest As
NORMEDICAL GROUP AS Board members of NORMEDICAL GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frank Loe Nylænde | Chairman | 0 companies |
| Fredrik Ove Haug Ringvold | Board of Directors | 0 companies |
| Per Torkel Rødland | Chairman | 0 companies |
| Terje Søbye | Chairman | 0 companies |